← All companies

ARGX

argenx SE

ARGX Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$830.79

-41.79 -4.79%

Key statistics

from XBRL data in SEC filings

Market cap

$51.4B

Revenue (TTM)

—

Net income (TTM)

-$163M

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$631.47 – $953.58

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K FORM 6-K Aug 3, 2026 6-K FORM 6-K Jul 27, 2026 6-K Jul 23, 2026 6-K FORM 6-K Jun 23, 2026 6-K FORM 6-K Jun 3, 2026 6-K FORM 6-K May 11, 2026 6-K May 7, 2026 6-K FORM 6-K May 6, 2026 6-K FORM 6-K Apr 20, 2026 6-K FORM 6-K Mar 20, 2026 20-F Mar 19, 2026 6-K Mar 19, 2026 6-K FORM 6-K Mar 6, 2026 6-K Feb 26, 2026 6-K FORM 6-K Feb 26, 2026 6-K FORM 6-K Jan 13, 2026 6-K FORM 6-K Jan 12, 2026 6-K FORM 6-K Jan 5, 2026 6-K FORM 6-K Dec 15, 2025 6-K FORM 6-K Nov 18, 2025 6-K Oct 30, 2025 6-K FORM 6-K Oct 29, 2025 6-K FORM 6-K Oct 15, 2025 6-K FORM 6-K Oct 3, 2025 6-K FORM 6-K Aug 25, 2025 6-K Jul 31, 2025 6-K FORM 6-K Jun 30, 2025 6-K FORM 6-K Jun 20, 2025 6-K FORM 6-K Jun 11, 2025 6-K FORM 6-K May 28, 2025 6-K May 8, 2025 6-K FORM 6-K Apr 28, 2025 6-K FORM 6-K Apr 14, 2025 6-K FORM 6-K Apr 11, 2025 6-K FORM 6-K Apr 8, 2025 20-F Mar 20, 2025 6-K Mar 20, 2025 6-K FORM 6-K Mar 7, 2025 6-K Feb 27, 2025 6-K FORM 6-K Jan 13, 2025